Direct-acting antivirals

Measurements taken for HCV cure at 4 weeks produced identical results for people who inject drugs as those taken at 12 weeks; Measurements taken at treatment completion also had high concordance. More

Integrating rapid diagnostics, low-barrier telemedicine, and harm-reduction support may improve hepatitis C outcomes for people who inject drugs in rural areas, highlighting the efficacy of mobile delivery systems over referral-based care. More